Cargando…

Assessment of antibody responses against SARS-CoV-2 in unvaccinated individuals and vaccinees from Omicron-BA.2 infection in Zhaoqing, Guangdong Province, China

Currently, the majority of the global population has been vaccinated with the COVID-19 vaccine, and characterization studies of antibodies in vivo from Omicron breakthrough infection and naive infection populations are urgently needed to provide pivotal clues about accurate diagnosis, treatment, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huan, Jiang, Yushan, Tan, Hanqing, Zou, Lirong, Zheng, Zhonghua, Huang, Yushi, Lin, Shujian, Su, Lebin, Yu, Jianxiang, Deng, Xiaoling, He, Jianfeng, Liu, Chang, Shen, Chenguang, Li, Baisheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701007/ https://www.ncbi.nlm.nih.gov/pubmed/36434614 http://dx.doi.org/10.1186/s12985-022-01912-0

Ejemplares similares

Screening and prenatal diagnosis of survival motor neuron gene deletion in pregnant women in Zhaoqing city, Guangdong Province
por: Huang, Zhiwei, et al.
Publicado: (2023)

An Imported Case of BA.2 Lineage of Omicron Variant COVID-19 — Guangdong Province, China, December 28, 2021
por: Guo, Qianfang, et al.
Publicado: (2022)

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
por: Andreano, Emanuele, et al.
Publicado: (2022)

First Imported Case of SARS-CoV-2 Omicron Subvariant BA.4 — Guangdong Province, China, May 4, 2022
por: Guo, Qianfang, et al.
Publicado: (2022)

First Imported Case of SARS-CoV-2 Omicron Subvariant BA.2.12.1 — Guangdong Province, China, April 30, 2022
por: Liang, Lijun, et al.
Publicado: (2022)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
por: Dapporto, Francesca, et al.
Publicado: (2022)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

An Imported Case and an Infected Close Contact of the Omicron Variant of SARS-CoV-2 — Guangdong Province, China, December 13, 2021
por: Li, Kuibiao, et al.
Publicado: (2022)

Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections
por: Tso, Winnie W.Y., et al.
Publicado: (2022)

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
por: Takahashi, Kenichiro, et al.
Publicado: (2022)

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
por: Anichini, Gabriele, et al.
Publicado: (2022)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
por: Rössler, Annika, et al.
Publicado: (2022)

Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2021)

An Outbreak of the SARS-CoV-2 Omicron Variant BA.1 — Zhuhai City, Guangdong Province, China, January 13, 2022
por: Ruan, Feng, et al.
Publicado: (2022)

A case of COVID-19-associated fulminant myocarditis due to SARS-CoV-2 Omicron BA.2 sub-lineage in an unvaccinated female
por: Ichimura, Shohei, et al.
Publicado: (2023)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections
por: Pedersen, Rune M., et al.
Publicado: (2022)

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
por: Yu, Pei, et al.
Publicado: (2023)

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
por: Santos da Silva, Eveline, et al.
Publicado: (2023)

Omicron targets upper airways in pediatrics, elderly and unvaccinated population
por: Nori, Wassan, et al.
Publicado: (2022)

Brucellosis in Guangdong Province, People’s Republic of China, 2005–2010
por: Chen, Jing-diao, et al.
Publicado: (2013)

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
por: He, Xiaofeng, et al.
Publicado: (2023)

Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation
por: Mileto, D., et al.
Publicado: (2022)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
por: Muik, Alexander, et al.
Publicado: (2022)

First Human Infection with Avian Influenza H9N2 — Guangdong Province, China, 2020
por: Guo, Qianfang, et al.
Publicado: (2020)

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
por: Zou, Jing, et al.
Publicado: (2022)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
por: Duan, Minrun, et al.
Publicado: (2023)

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
por: Cao, Yunlong, et al.
Publicado: (2022)

Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees
por: Inoue, Takeshi, et al.
Publicado: (2022)

Comparison of Four T-cell Assays and Two Binding Antibody Assays in SARS-CoV-2 Vaccinees With or Without Omicron Breakthrough Infection
por: Seo, Yeon Ju, et al.
Publicado: (2023)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Two Imported Cases of New Variant COVID-19 First Emerging in Nigeria — Guangdong Province, China, March 12, 2021
por: Hu, Yao, et al.
Publicado: (2021)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
por: Yang, Jinyoung, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
por: Evans, John P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r7p9hvdmh45d1u20nt2to8fds0